Results 131 to 140 of about 2,325,434 (292)

Expression of Mineralocorticoid and Glucocorticoid receptors in Pre‐autonomic Neurons of the Rat Paraventricular Nucleus

American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 2013
Jian Chen, C. Gomez-Sanchez, P. May, E. Gomez-Sanchez   +3 more
semanticscholar   +1 more source

Validation of grizzly bear hair hormone profiles as a tool to monitor population demographics

The Journal of Wildlife Management, Volume 90, Issue 2, February 2026.
We measured 16 steroid and thyroid hormone concentrations in grizzly bear hair to predict sex, age class, and reproductive status. Models were highly accurate when predicting sex and age class and showed promise for assessing reproductive status. Results illustrate the potential for hair hormone profiles as non‐invasive population monitoring tools ...
Abbey E. Wilson, Cameron J. R. McClelland, Sarah A. Michaud, Jun Han, Gordon Stenhouse, David R. Goodlett, Kristenn Magnusson, Karen Graham, Hugo Fernández‐Bellon, David M. Janz, Darío Fernández‐Bellon   +10 more
wiley   +1 more source

Central Mineralocorticoid Receptors and the Role of Angiotensin II and Glutamate in the Paraventricular Nucleus of Rats With Angiotensin II–Induced Hypertension

HYPERTENSION, 2013
A. Gabor, F. Leenen
semanticscholar   +1 more source

Recurrent haemorrhage, due to vitamin K‐dependent coagulopathy, as the primary presenting complaint in a dog with naturally occurring hypoadrenocorticism

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 5‐year‐old male neutered standard poodle, presented with recurrent gingival margin haemorrhage and associated prolongations in prothrombin time and activated partial thromboplastin time, with repeatable demonstration of clinical (bleeding) and laboratory (prothrombin time, activated partial thromboplastin time) resolution with, and relapse ...
Jenny Reeve, Aiden Pang
wiley   +1 more source

Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines. [PDF]

Biomolecules
Kohm E, Feger M, Föller M.
europepmc   +1 more source

Antagonism of Kinin Receptors B1 and B2 Attenuates Folic Acid‐Induced Tubulointerstitial Fibrosis in Mice

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 2, February 2026.
ABSTRACT Chronic kidney disease (CKD) remains a significant global health burden despite recent advances in pharmacotherapy, including sodium‐glucose cotransporter 2 (SGLT2) inhibitors and mineralocorticoid receptor antagonists. Renal fibrosis, a central pathological hallmark of CKD progression, is mediated by persistent inflammation and macrophage ...
Gabriel Rufino Estrela, Alexandre Budu, Juliene Silva, Raisa Brito, Frederick Wasinski, Jonatan Barrera‐Chimal, Ronaldo Carvalho Araujo   +6 more
wiley   +1 more source

A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)

Clinical Endocrinology, Volume 104, Issue 2, Page 113-122, February 2026.
ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea, Frédérique Lefrançois, Matthieu St‐Jean, Anne‐Marie Côté, Marie‐Ève Roy‐Lacroix, Mandy Malick, Pierre‐Luc Mallet, Nadine Sauvé   +7 more
wiley   +1 more source

Microvillus Inclusion Disease: Successful Treatment of Severe Hyponatremia With High-Dose Fludrocortisone via a Possible Gut-Mediated Mechanism. [PDF]

ACG Case Rep J
Alsarhan A, Saffarini Z, Tzivinikos C, Bitzan M, Thalange N.   +4 more
europepmc   +1 more source

Cardiomyocyte Mineralocorticoid Receptors Are Essential for Deoxycorticosterone/Salt-Mediated Inflammation and Cardiac Fibrosis

HYPERTENSION, 2012
A. Rickard, J. Morgan, Laura A Bienvenu, E. Fletcher, G. Cranston, Jimmy Shen, M. Reichelt, L. Delbridge, M. Young   +8 more
semanticscholar   +1 more source

Baseline characteristics in the SYNCHRONIZE™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP‐1 receptor dual agonist, for obesity in people with type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1490-1498, February 2026.
Abstract Aims Survodutide is an investigational glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist that has shown promise for treating obesity and its complications in Phase 2 trials. Two double‐blind, randomized, global Phase 3 trials are designed to assess the efficacy and safety of survodutide for treatment of obesity—SYNCHRONIZE™‐1 in ...
Sean Wharton, Carel W. le Roux, Biykem Bozkurt, Elke Platz, Gabriele Bleckert, Samina Ajaz Hussain, Martina Brueckmann, Elena Startseva, Isabel M. Kloer, Lee M. Kaplan   +9 more
wiley   +1 more source